We have two marketed products, approved in the U.S. and Europe.
NEXLETOL®
Please see full U.S. Prescribing Information for NEXLETOL.
U.S. healthcare professionals, for more information, please visit nexletolhcp.com.
U.S. patients, for more information, please visit nexletol.com.
To learn more about bempedoic acid in Europe, visit our partner Daiichi-Sankyo Europe.
To learn more about the mechanism of action, please visit nexlizethcp.com/mechanism-of-action.
NEXLIZET®
Please see full U.S. Prescribing Information for NEXLIZET.
U.S. healthcare professionals, for more information, please visit nexlizethcp.com.
U.S. patients, for more information, please visit nexlizet.com.
To learn more about the bempedoic acid and ezetimibe combination in Europe, visit our partner Daiichi-Sankyo Europe.
To learn more about the mechanism of action, please visit nexlizethcp.com/mechanism-of-action.